Drugmaker halves price of Ozempic for Americans amid Trump crackdown
The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…
Trading in Novo Nordisk shares by board members, executives and associated persons
Novo Nordisk A/S Bagsværd, Denmark, 19 August 2025 — This company announcement discloses the data of the transaction(s) made…
Eli Lilly’s weight-loss breakthroughs face brutal investor scrutiny – The Irish Times
Eli Lilly’s latest earnings and trial results offered plenty to celebrate. Its orforglipron pill helped participants shed an…
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines
Ozempic® is the GLP-1 with the most FDA-approved uses for patients with type 2 diabetes including, improvement of…
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
“Today’s decision by the FDA reflects the continued progress in how we understand and treat patients with MASH,…
Scientists Find Common Kitchen Appliance May Increase Your Risk of Type 2 Diabetes
“Hearst Magazines and Yahoo may earn commission or revenue on some items through these links.” A new study…